Amgen, Inc. (NASDAQ:AMGN)

CAPS Rating: 4 out of 5

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

Results 1 - 20 of 346 : 1 2 3 4 5 6 7 8 9 10 Next »

Recs

0
Member Avatar optioncoach (83.48) Submitted: 12/10/2015 4:26:42 PM : Outperform Start Price: $157.82 AMGN Score: -0.52

I think that biotech has made it through the negative news, and the quality names are the place to be. The political landscape is going to create fear in the sector and you will hear don't go there from the pundits. I say get after the high quality now that we have shook out and the American Population continues to age. The need is there!

Recs

0
Member Avatar MotoJ (41.05) Submitted: 12/4/2015 4:24:54 PM : Outperform Start Price: $162.91 AMGN Score: -0.80

It always has outperformed the S&P 500. Superior company with superior products.

Recs

0
Member Avatar CMFLovePeace (< 20) Submitted: 10/29/2015 11:13:38 AM : Outperform Start Price: $162.83 AMGN Score: -1.08

Curing cancer and paying a dividend, plus plus.

Recs

0
Member Avatar freecapital (65.37) Submitted: 10/13/2015 9:34:36 AM : Outperform Start Price: $150.85 AMGN Score: +2.59

smead

Recs

0
Member Avatar 401ktimer1 (37.96) Submitted: 8/31/2015 12:01:45 PM : Outperform Start Price: $153.02 AMGN Score: +0.19

http://blogs.barrons.com/stockstowatchtoday/2015/08/28/gilead-amgen-account-for-nearly-75-of-the-biotech-profit-pool/?mod=yahoobarrons&ru=yahoo

Recs

0
Member Avatar FVelociraptor (99.43) Submitted: 8/16/2015 4:12:48 PM : Outperform Start Price: $166.21 AMGN Score: -2.79

TT

Recs

0
Member Avatar LifeForceDancr (22.67) Submitted: 8/14/2015 3:43:14 PM : Outperform Start Price: $167.18 AMGN Score: -2.96

best biotech

Recs

0
Member Avatar Yobberman (< 20) Submitted: 5/28/2015 9:30:50 PM : Outperform Start Price: $155.28 AMGN Score: +4.91

It's a good-lookin' stock

Recs

0
Member Avatar Kimer62 (22.79) Submitted: 5/9/2015 8:43:24 AM : Outperform Start Price: $159.43 AMGN Score: +2.19

value and conservative

Recs

0
Member Avatar Herbstmd (36.07) Submitted: 4/17/2015 8:39:24 PM : Outperform Start Price: $162.25 AMGN Score: -0.51

New drugs in testing include a possible block buster new cholesterol treatment that will out do the entire statin field. A real blockbuster. Akso nice dividend. I see this as stable and rising with the PE of 24 readonable.

Recs

0
Member Avatar Neowalkit (58.19) Submitted: 4/2/2015 2:13:35 PM : Outperform Start Price: $154.23 AMGN Score: +3.11

It has performed well in the past and I don't see that there is any reason for it to change

Recs

0
Member Avatar mobiusstrip (68.72) Submitted: 4/1/2015 12:00:08 PM : Outperform Start Price: $154.84 AMGN Score: +2.15

Been watching this stock for years and frustrated as it kept going up each time I wanted to buy, but not pulling the trigger. Dividend growth is fantastic, and I can jump in at a 2% yield today after 2 straight down days. Earnings expected to be well over $10/share within a year or two, so a doubling of the dividend or more in the next 3 years is entirely supported by income growth.

Recs

0
Member Avatar TMFTypeoh (74.44) Submitted: 3/24/2015 9:08:50 PM : Outperform Start Price: $163.59 AMGN Score: -1.24

Company is set on increasing operating margin by cutting costs and increasing prices. New drugs on the way should boost revenue and a buyback with a fast growing dividend should propel Amgen ever higher.

Recs

0
Member Avatar factoids (44.46) Submitted: 3/20/2015 11:00:52 AM : Outperform Start Price: $167.07 AMGN Score: -2.51

AMGN has high dividend and EPS growth at a reasonable yield

Recs

0
Member Avatar CellBlock9 (89.86) Submitted: 2/8/2015 12:09:57 PM : Outperform Start Price: $147.05 AMGN Score: +6.85

mgk, S&P 4 star

Recs

0
Member Avatar manirg (< 20) Submitted: 2/5/2015 11:13:33 AM : Outperform Start Price: $148.37 AMGN Score: +6.33

undervalued, a super pipeline

Recs

0
Member Avatar TheDumbMoney (68.52) Submitted: 1/26/2015 11:01:54 AM : Outperform Start Price: $157.81 AMGN Score: +0.21

Bought 30 shares at $159.62, in IRA, no commission.

Recs

1
Member Avatar handballjones (< 20) Submitted: 1/14/2015 9:13:37 PM : Outperform Start Price: $153.08 AMGN Score: +1.53

Pipeline has a lot of pent up pop pending, the company has become very dynamic while now watching costs, plus looks to be sharing more wealth with it stakeholder (shareholders).

Recs

1
Member Avatar Rayliu25 (< 20) Submitted: 12/10/2014 4:06:11 PM : Outperform Start Price: $163.42 AMGN Score: -3.43

Leading the biotech revolution

Recs

0
Member Avatar afewgoodstocks14 (< 20) Submitted: 5/13/2014 1:33:33 PM : Outperform Start Price: $108.55 AMGN Score: +33.36

Div. (Yield) $2.44 (2.2%)

Featured Broker Partners